James Edgemond

2015

In 2015, James Edgemond earned a total compensation of $3M as Chief Financial Officer and Treasurer at United Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$216,000
Option Awards$2,402,371
Salary$380,146
Other$13,400
Total$3,011,917

Edgemond received $2.4M in option awards, accounting for 80% of the total pay in 2015.

Edgemond also received $216K in non-equity incentive plan, $380.1K in salary and $13.4K in other compensation.

Rankings

In 2015, James Edgemond's compensation ranked 3,158th out of 13,638 executives tracked by ExecPay. In other words, Edgemond earned more than 76.8% of executives.

ClassificationRankingPercentile
All
3,158
out of 13,638
77th
Division
Manufacturing
1,135
out of 5,190
78th
Major group
Chemicals And Allied Products
416
out of 1,854
78th
Industry group
Drugs
329
out of 1,528
79th
Industry
Pharmaceutical Preparations
263
out of 1,182
78th
Source: SEC filing on April 28, 2017.

Edgemond's colleagues

We found five more compensation records of executives who worked with James Edgemond at United Therapeutics in 2015.

2015

Roger Jeffs

United Therapeutics

Chief Executive Officer

2015

John Ferrari

United Therapeutics

Chief Financial Officer

2015

Paul Mahon

United Therapeutics

General Counsel

2015

David Zaccardelli

United Therapeutics

Chief Operating Officer

2015

Martine Rothblatt

United Therapeutics

Chief Executive Officer

News

In-depth

You may also like